|
Volumn 81, Issue 12, 2006, Pages 675-682
|
Intravitreal bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema;Sistema intravítreo bioerudivel de liberación prolongada de microesferas de triamcinolona (RETAAC). Comunicación preliminar de su utilidad potencial para el tratamiento del edema macular diabético
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
GLYCOLIC ACID DERIVATIVE;
MICROSPHERE;
POLY (LACTIC CO GLYCOLIC ACID);
POLY (LACTIC-CO-GLYCOLIC ACID);
TRIAMCINOLONE ACETONIDE;
UNCLASSIFIED DRUG;
DELAYED RELEASE FORMULATION;
DIABETES MELLITUS;
DRUG SCREENING;
EDITORIAL;
HUMAN;
INJECTION;
PILOT STUDY;
RETINA MACULA CYSTOID EDEMA;
VITREOUS BODY;
ANTI-INFLAMMATORY AGENTS;
DELAYED-ACTION PREPARATIONS;
DIABETES COMPLICATIONS;
DRUG EVALUATION;
GLYCOLATES;
HUMANS;
INJECTIONS;
MACULAR EDEMA, CYSTOID;
MICROSPHERES;
PILOT PROJECTS;
TRIAMCINOLONE ACETONIDE;
VITREOUS BODY;
|
EID: 34248214266
PISSN: 03656691
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (50)
|
References (5)
|